278
Views
55
CrossRef citations to date
0
Altmetric
Original Article

Ig-binding Receptors on Human NK Cells as Effector and Regulatory Surface Molecules

, , &
Pages 371-414 | Published online: 10 Jul 2009
 

Abstract

The receptors on human natural killer 9NK cells which can specifically bind the Fc portion of immunoglobulin molecules (Fc receptors) have been extensively studied. The best known and studied Fc receptor on human NK cells is FcγRIIIa. Interactions of NK cells with IgG antibodies via this receptor are well known to induce a signal transduction cascade and lead to antibody-dependent cell-mediated cytotoxicity (ADCC) as well as release of various cytokines. In addition, interactions with monomeric IgG and FcγRIIIa have been demonstrated, which result in negative regulation of NK activity and other immunomodulatory effects. Over the past several years, it has also become increasingly appreciated that human NK cells express a variety of other Fc receptors, including FcμR, which also can mediate effector and immunoregulatory functions. Also, a novel form of FcγR has been demonstrated on human NK cells, termed FcγRIIc. Recent molecular studies have shown considerable polymorphism in the genes for FcγIIc and the functional consequences are being dissected. This appears to include cross-talk between FcγRIIIa and at least some forms of FcγRIIc, which may have important functional consequences.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.